Clinical Trials · NCT05232708
A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 18
- Start date
- Jan 2022
- Locations
- 1 site, United Kingdom
- Primary endpoint
- AUC0-last,sema 0.5mg: Area under the semaglutide concentration-time curve from time 0 until last quantifiable measurement after single dose of s.c. semaglutide 0.5 mg